The majority of voters are concerned about drug prices.
The growth in employees’ share of health-care premiums and deductibles has slowed over the past decade, but their incomes have lagged behind, according to a new study.
The industry's trade group is preparing for a fight over prescription drug costs after the presidential election.
On one hand, gene technology could reveal powerful information about babies' disease risk that could prevent illness or manage it. But the insights could also be complicated and unnecessarily worrisome because of the evolving and incomplete scientific understanding of what it means to carry a particular version of a gene.
What a medical emergency on a plane can teach us about implicit bias.
The economic argument for getting vaccinated.
A third of hospitals said drug prices had a “severe” effect on their budget.
Questions have swirled around whether Mylan paid big enough rebates to Medicaid
Studies are finding significant quality-of-life boosts for older Americans in medical marijuana states.
Elderly patients were even more likely to delay the start of treatment.
Mylan plans to extend the shelf life of Epipen
Mylan calculated its profits at a tax rate that is more than five times the overall tax rate the company actually paid.
Fewer people take opioids in states with medical marijuana laws.
The number of patients who outlived hospice care in the United States has risen dramatically, in part because hospice companies earn more by recruiting patients who aren’t actually dying.